Contact
Please use this form to send email to PR contact of this press release:
Tysabri (natalizumab): Drug Safety Communication - New Risk Factor for Progressive Multifocal Leukoencephalopathy (PML)
TO:
Please use this form to send email to PR contact of this press release:
Tysabri (natalizumab): Drug Safety Communication - New Risk Factor for Progressive Multifocal Leukoencephalopathy (PML)
TO: